Lymphoma in senior dogs: symptoms, treatment and prognosis

For many owners, the diagnosis begins with a hand under the jaw. You are scratching your senior dog's ears or rubbing his neck the way you have a thousand times before, and your fingers find something that should not be there — a firm, smooth lump, sometimes the size of an olive, sometimes the size of a small egg. There may be one on each side. He does not flinch when you press it. He is eating, walking, wagging at the door. And yet within a week, your veterinarian has used the word that no one wants to hear: lymphoma.

Lymphoma is one of the most common cancers in dogs, accounting for roughly 7 to 14 percent of all canine cancer diagnoses, and it strikes most often between the ages of 6 and 9. It is a cancer of the lymphocytes, the white blood cells that patrol the body's immune system, and because lymphocytes live everywhere — in lymph nodes, the spleen, the gut, the bone marrow, the skin — lymphoma can appear in many different forms with very different behaviors and outlooks.

The harder truth and the gentler one arrive together. Most forms of lymphoma in dogs cannot be cured. But unlike many cancers, lymphoma is unusually responsive to chemotherapy, and a large majority of dogs treated with the modern protocols feel substantially better within days and live comfortable, recognizable months — often a year or more — after diagnosis. This guide explains what lymphoma actually is, how it is diagnosed and staged, the full range of treatment options, what to realistically expect from each, and how to support a dog through the months that follow.

What lymphoma actually is

The lymphatic system is a network of vessels, organs, and tissues that runs throughout the body. Lymph nodes — small bean-shaped filters scattered along that network — sit in clusters under the jaw, in front of the shoulders, behind the knees, in the armpits, in the groin, and deep inside the chest and abdomen. The system carries a clear fluid called lymph, which is full of white blood cells called lymphocytes. Those lymphocytes are part of the immune system and come in two main families: B-cells, which produce antibodies, and T-cells, which coordinate immune responses and attack infected cells directly.

Lymphoma is a cancer in which lymphocytes — typically B-cells, sometimes T-cells — begin to multiply uncontrollably and accumulate in the tissues where they live. Because lymphocytes are everywhere, lymphoma is not really a single disease but a family of diseases that share a common cell of origin. A dog with lymphoma in his peripheral lymph nodes behaves very differently from a dog with lymphoma in his intestines or his chest, even though the underlying cancer cell is similar. The location, the cell type, and the way the disease spreads all shape what owners and veterinarians experience.

Why senior dogs develop lymphoma

The honest answer is that we do not know exactly why most dogs develop lymphoma. There is no single cause, and unlike some cancers, lymphoma is rarely the result of one identifiable trigger. What is known is that the disease has a clear genetic component — certain breeds are far more likely to develop it than others — and that the risk increases with age, with most cases occurring in middle-aged and senior dogs.

Boxers, Golden Retrievers, Bullmastiffs, Basset Hounds, Saint Bernards, Scottish Terriers, Airedales, and Bulldogs all have an above-average risk. Golden Retrievers are particularly affected — some studies estimate that as many as one in eight Goldens will develop lymphoma in their lifetime. Environmental factors have been studied (lawn herbicides, magnetic fields, secondhand smoke, certain industrial chemicals), and a few have shown weak associations, but for most individual dogs the cancer arrives without a clear cause to point to. Owners often blame themselves and search for what they should have done differently. They almost never could have prevented it.

Types of canine lymphoma

Veterinary oncologists classify lymphoma by where in the body it appears. Five main forms account for almost all cases, and the type matters because it changes the symptoms, the diagnostic approach, and the outlook.

Multicentric lymphoma

This is by far the most common form, accounting for roughly 80 to 85 percent of canine lymphoma cases, and it is the form most owners discover first. The cancer settles in multiple peripheral lymph nodes — those firm, painless swellings under the jaw, in front of the shoulders, in the armpits, in the groin, and behind the knees. The lymph nodes can grow rapidly, sometimes doubling in size within a week. Most dogs feel surprisingly well in early multicentric lymphoma, which is why the diagnosis often comes as such a shock.

Alimentary (gastrointestinal) lymphoma

Alimentary lymphoma affects the stomach, intestines, and associated lymph nodes. It accounts for roughly 5 to 7 percent of canine lymphomas and tends to cause vomiting, diarrhea, weight loss, and loss of appetite that are often mistaken for inflammatory bowel disease, dietary intolerance, or a slow gastrointestinal foreign body. Diagnosis usually requires biopsies, often obtained by endoscopy or surgery. Alimentary lymphoma in dogs is generally less responsive to standard chemotherapy than the multicentric form, and the outlook tends to be more guarded.

Mediastinal lymphoma

Mediastinal lymphoma develops in the lymph nodes and thymic tissue inside the chest. It is far less common than the multicentric form but can be dramatic when it appears, because a large mass in the chest crowds the lungs and major vessels. Affected dogs often present with rapid breathing, exercise intolerance, coughing, swelling of the face and front legs (from compressed veins), or fluid accumulation around the lungs. Mediastinal lymphoma is most often a T-cell disease and frequently comes with elevated blood calcium (hypercalcemia), which complicates kidney function.

Cutaneous (skin) lymphoma

Cutaneous lymphoma affects the skin and sometimes the mucous membranes inside the mouth. It can look very different from one dog to another — flaky patches, raised plaques, red ulcerated areas, mouth lesions, or generalized scaly inflammation that mimics chronic skin disease. Many dogs are initially treated for allergies or autoimmune disease for months before a biopsy reveals the true diagnosis. Cutaneous lymphoma is most often a T-cell disease and is generally slower-progressing than other forms, but it is also more difficult to put into lasting remission.

Other forms

Less commonly, lymphoma can develop primarily in the central nervous system (causing seizures or neurological signs), in the eye (causing inflammation, redness, or blindness), in the bone marrow (causing low blood counts), in the liver and spleen, or in the kidneys. These extranodal forms are uncommon but important to recognize, because their symptoms often look like other diseases first.

The signs and symptoms

Because lymphoma can appear in so many tissues, the symptoms vary widely. The most useful framework is to know the classic presentation — peripheral lymph node enlargement — while remaining alert to the less obvious signs that signal the other forms.

Swollen lymph nodes

Painless, firm enlargement of the peripheral lymph nodes is the hallmark of multicentric lymphoma. Owners usually find one first, often under the jaw or in front of the shoulder, while petting their dog. The nodes feel like firm rubbery balls beneath the skin. They are not usually tender. They may grow noticeably larger within days. Any persistent lymph node enlargement in a senior dog should prompt an immediate veterinary appointment, because early diagnosis gives the best chance of a strong response to treatment.

Lethargy and reduced energy

Many dogs are surprisingly normal when lymphoma is first found, but as the disease progresses they often slow down, sleep more, lose enthusiasm for walks, or seem mildly "off." Because these changes are subtle and easy to attribute to age, the lymph node finding sometimes ends up being the more telling clue.

Loss of appetite and weight loss

A dog who suddenly leaves food in his bowl, loses interest in treats, or starts eating less for several days in a row is showing one of the most reliable early signs that something systemic is wrong. Gradual, unexplained weight loss in a senior dog is always worth investigating. In dogs with alimentary lymphoma, appetite loss often accompanies vomiting and diarrhea.

Vomiting, diarrhea, and other GI signs

Alimentary lymphoma frequently causes intermittent or progressive vomiting, soft stools or diarrhea, blood in the stool, and weight loss. Many of these dogs are initially treated for inflammatory bowel disease or dietary upset. A senior dog with persistent GI symptoms that do not resolve with standard treatment deserves a more thorough workup, often including ultrasound and biopsies.

Increased thirst and urination

Some dogs with lymphoma — particularly those with T-cell mediastinal disease — develop high blood calcium, which causes increased thirst, increased urination, and sometimes weakness. Owners often think their dog has developed kidney disease or diabetes; bloodwork reveals the calcium abnormality and prompts the search for an underlying cause.

Difficulty breathing

Mediastinal lymphoma can cause coughing, fast or labored breathing, exercise intolerance, or difficulty lying flat. In some cases, fluid builds up around the lungs (pleural effusion), which can rapidly become life-threatening. A senior dog with new respiratory symptoms always needs urgent evaluation.

Skin changes

Cutaneous lymphoma can present as patchy hair loss, redness, scaling, raised plaques, or ulcers — sometimes scattered, sometimes widespread. Mouth involvement may show as red, painful, or ulcerated areas on the gums, tongue, or hard palate. Persistent skin disease that does not respond to standard treatment in a senior dog should prompt a biopsy.

Other signs

Depending on where the cancer settles, dogs may show pale gums (from anemia), unexplained bruising, swollen face or front legs, jaundice, sudden blindness or eye inflammation, or seizures. The diversity of presentations is part of why lymphoma is sometimes called "the great imitator."

How lymphoma is diagnosed

Diagnosis usually moves quickly once a suspicious lymph node is found. The full workup combines a confirmation of the cancer itself with staging tests that map how far the disease has spread.

Fine-needle aspirate and cytology

The first step is almost always a fine-needle aspirate of an enlarged lymph node — a quick, in-clinic procedure that uses a small needle to collect cells. The cells are smeared on a slide and examined under a microscope, often by a veterinary clinical pathologist. For multicentric lymphoma, cytology alone is usually enough to confirm the diagnosis. The procedure takes minutes, requires no anesthesia, and gives an answer within a day or two.

Biopsy

For some forms — particularly alimentary, cutaneous, and certain unusual presentations — a tissue biopsy is needed. Biopsies require sedation or anesthesia and are processed by a veterinary pathologist over several days. They confirm the diagnosis, determine the cell type more precisely, and rule out other look-alikes.

Immunophenotyping (B-cell vs T-cell)

Once lymphoma is confirmed, the next critical question is whether the cells are B-cells or T-cells. Flow cytometry, immunohistochemistry, or a PARR (PCR for Antigen Receptor Rearrangement) test can answer this from a small sample. The distinction matters enormously: B-cell lymphomas generally respond better and longer to chemotherapy than T-cell lymphomas, and oncologists sometimes adjust treatment based on the result.

Staging tests

Staging maps the extent of the disease and helps refine prognosis. A typical workup includes a complete blood count, chemistry panel, urinalysis, chest x-rays, and abdominal ultrasound. Some oncologists also recommend a bone marrow aspirate, particularly when blood counts are abnormal. Lymphoma is staged from I (a single lymph node) to V (involvement of bone marrow, blood, or other organs), with substages a (no clinical signs) and b (clinical signs of illness). Most dogs diagnosed with multicentric lymphoma are stage III to V at presentation, simply because the disease has usually spread to multiple nodes by the time anyone notices.

Treatment options

Lymphoma is one of the most treatable cancers in veterinary medicine. The goal of treatment is rarely cure — it is to put the disease into remission, restore quality of life, and extend comfortable time. Modern protocols are far gentler than human chemotherapy, and most dogs continue to feel like themselves throughout treatment.

CHOP multi-agent chemotherapy

CHOP is the gold standard for canine multicentric B-cell lymphoma and the protocol most veterinary oncologists recommend first. The name is an acronym for the four drugs used in rotation: Cyclophosphamide, Hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and Prednisone. The drugs are given on a weekly schedule for several weeks, then every two weeks, over a 19- to 25-week course. Around 80 to 90 percent of dogs with B-cell lymphoma reach remission on a CHOP protocol, with median survival of approximately 12 months and roughly 20 to 25 percent of dogs alive at two years. T-cell dogs respond less reliably and for shorter periods, with median survival typically in the 6- to 9-month range.

Single-agent chemotherapy

For families who cannot pursue full CHOP — because of cost, distance from a specialty hospital, or a personal preference for less intensive care — single-agent protocols using doxorubicin alone, or using oral lomustine, are reasonable alternatives. Single-agent doxorubicin produces remission in about 75 percent of B-cell dogs with median survival of 6 to 8 months. The schedule is simpler and the time commitment lighter, even if the long-term outcome is somewhat shorter.

Prednisone alone

Prednisone is an inexpensive oral steroid that quickly shrinks lymph nodes in many dogs and helps them feel better for a period of time. It is not a true cancer treatment — it does not target the cancer cells in the way chemotherapy does — and dogs treated with prednisone alone usually have a median survival of only 1 to 3 months. Importantly, dogs who have received prednisone alone often do not respond as well to subsequent chemotherapy, because the disease has had time to develop resistance. If you are considering chemotherapy, talk to your veterinarian before starting steroids.

Tanovea-CA1 (rabacfosadine)

Tanovea is the first FDA-conditionally-approved drug specifically for canine lymphoma. It is given by intravenous infusion every three weeks for up to five doses. Response rates are similar to single-agent doxorubicin, and Tanovea is sometimes used as a first-line treatment, as a second-line option after CHOP relapse, or for dogs who do not tolerate doxorubicin. It has become a useful addition to the oncologist's toolbox.

Radiation therapy

Radiation has a more limited role in canine lymphoma than in many other cancers because the disease is usually distributed throughout the body. It is most useful for localized stage I lymphoma confined to a single site, or as an additional tool for residual disease after chemotherapy. Half-body radiation has been studied as a consolidation strategy for some patients in remission.

Bone marrow transplant

Bone marrow transplantation is available at a small number of veterinary specialty hospitals and offers the only realistic chance of long-term cure for select dogs with B-cell lymphoma. The procedure requires several weeks of inpatient treatment, costs in the range of $20,000 or more, and is appropriate for a relatively small subset of patients who are otherwise healthy and in early remission. For families for whom it is feasible, transplant survival data are encouraging, with approximately a third to half of treated dogs achieving long-term remission.

Palliative care

For families who choose not to pursue chemotherapy — because of cost, age, comorbidities, or personal values — supportive palliative care is a respectable and compassionate path. This typically includes prednisone, antinausea and antidiarrheal medications as needed, appetite support, and careful attention to comfort. Many of these dogs have one to three good months before the disease progresses, and a thoughtful palliative plan can make those months meaningful and peaceful.

What to expect during treatment

Veterinary chemotherapy is consciously designed to preserve quality of life. Doses are calibrated to slow or stop the cancer while keeping side effects mild. Most dogs continue going on walks, eating normally, and behaving like themselves throughout treatment.

Side effects

Roughly 75 to 80 percent of dogs experience minimal or no side effects. Of those who do, the most common issues are mild nausea, soft stools or diarrhea, transient loss of appetite, and temporary fatigue lasting 2 to 4 days after a treatment. About 5 percent of dogs have more significant reactions that require hospitalization for fluids and supportive care. Unlike humans, dogs rarely lose their hair from chemotherapy; only certain breeds with continuously growing coats — Poodles, Bichons, Old English Sheepdogs, and a few others — may experience noticeable thinning, and whiskers commonly fall out across all breeds.

Vet visit schedule

A typical CHOP course involves weekly to biweekly visits for treatment and bloodwork. Each visit takes 1 to 3 hours. The blood count is checked every time to make sure the bone marrow is recovering between doses; if the count is low, that week's drug is delayed. Most dogs come to recognize the staff and tolerate visits well.

Cost

Cost varies widely by region and by protocol. A full CHOP course at a specialty hospital typically runs $6,000 to $10,000, including drugs, bloodwork, and rechecks. Single-agent protocols run roughly $2,000 to $4,000. Tanovea is often in a similar range to single-agent chemotherapy. Prednisone-only palliative care is inexpensive — usually under a few hundred dollars over the course of treatment. Pet insurance, payment plans, and nonprofit assistance funds can sometimes help, and many oncologists have honest conversations with families about what is feasible.

Prognosis: what to realistically expect

Prognosis depends on the type of lymphoma, the cell phenotype, the stage, the substage, and how the dog responds to the first round of treatment. The numbers below are medians, which means half of dogs do better and half do worse.

• B-cell multicentric lymphoma with CHOP: approximately 80 to 90 percent achieve remission; median survival around 12 months; about 20 to 25 percent alive at 2 years.
• T-cell multicentric lymphoma with CHOP: remission rates somewhat lower; median survival around 6 to 9 months for most subtypes, with notable variation.
• Single-agent doxorubicin (B-cell): remission in about 75 percent; median survival 6 to 8 months.
• Prednisone alone: median survival 1 to 3 months; quality of life often improves temporarily.
• Untreated: median survival 4 to 6 weeks from diagnosis, often less for advanced disease.
• Alimentary lymphoma: generally a more guarded prognosis than multicentric, with median survival in the 3- to 9-month range depending on cell type and treatment.
• Cutaneous T-cell lymphoma: often slowly progressive over months to a year or more, but lasting remissions are uncommon.
• Bone marrow transplant (B-cell, in remission): approximately one-third to one-half of treated dogs achieve long-term remission lasting two years or more.

These numbers are generalizations across many dogs. They are not predictions for your dog. Some dogs sail through treatment with deep remissions and live well past the medians; others relapse early. A board-certified veterinary oncologist can offer a more individualized estimate based on bloodwork, immunophenotype, and how the cancer responds to the first few treatments.

Supporting your dog at home

Daily care during and after treatment focuses on comfort, nutrition, monitoring, and protecting the immune system. None of it is complicated, but consistency matters.

Nutrition

A high-quality, palatable diet helps maintain weight and energy. Some oncologists recommend slightly higher-protein, moderately-higher-fat, lower-carbohydrate foods for dogs with lymphoma, on the theory that cancer cells preferentially use carbohydrate for energy. The evidence for this approach is modest, but a well-formulated diet that the dog actually eats consistently is more important than any specific theory. Warming food, hand-feeding, and occasional bland additions (boiled chicken, plain rice, pumpkin) can help during the few days of reduced appetite that sometimes follow a chemotherapy dose.

Monitoring at home

Track lymph node size with a soft tape measure or by noting their feel; many oncologists ask owners to check the prescapular and submandibular nodes weekly. Watch for new swellings, persistent vomiting or diarrhea, refusal to eat for more than a day or two, lethargy beyond what is normal for that dog, fever, or unusual bruising. Keep a simple notebook or app log; trends matter more than single readings.

Avoiding infection

Chemotherapy temporarily lowers white blood cell counts in the days after each dose, leaving dogs slightly more vulnerable to infection. Avoid dog parks, kennels, and crowds during low-count periods, keep wounds clean, and call your veterinarian for a fever, lethargy, or vomiting that persists more than 24 hours.

Handling chemotherapy drugs safely

For 48 to 72 hours after a chemotherapy dose, small amounts of drug may be excreted in urine, stool, and saliva. Wear gloves when picking up waste, flush twice, wash bedding separately, and avoid letting your dog lick young children, pregnant family members, or immunocompromised individuals during this window. Your oncology team will give you a specific handout. The risk is small, but reasonable precautions are easy.

Comfort and routine

Most dogs benefit from a predictable routine during treatment. Familiar walks, favorite resting spots, gentle play, and steady mealtimes provide a stable backdrop while the body works through chemotherapy. The dog who was the same dog before the diagnosis is still the same dog after it; treatment is something you do alongside everyday life, not instead of it.

What to avoid

• Starting prednisone before talking to your veterinarian about chemotherapy. A few weeks of steroid alone can reduce how well subsequent chemotherapy works.
• Skipping the immunophenotype test. B-cell vs T-cell knowledge meaningfully changes prognosis and sometimes the protocol.
• Comparing your dog to humans on chemotherapy. Veterinary chemotherapy is dosed for quality of life, and most dogs do not experience the severity of side effects that human patients sometimes do.
• Waiting to see if the lymph nodes go down on their own. They will not. Time matters; earlier treatment usually means deeper, longer remissions.
• Unproven alternative therapies as a substitute for treatment. Many supplements and herbal protocols are reasonable as additions to evidence-based treatment after a conversation with the oncologist, but very few have been shown to slow lymphoma on their own.
• NSAIDs and certain other drugs while on prednisone. Combinations of steroids and human anti-inflammatories can cause severe GI ulceration. Always confirm with your veterinarian before giving anything new.

When to see the vet

Beyond the regular treatment schedule, several changes warrant calling your veterinary team between appointments.

Call soon if your dog shows:

• Lymph nodes that begin growing again during treatment (a sign of relapse)
• Persistent vomiting or diarrhea lasting more than a day
• Refusal to eat for more than 24 to 36 hours
• Lethargy beyond the typical 2- to 3-day post-treatment dip
• Pale gums or noticeable bruising
• Increased thirst and urination, especially with a known T-cell diagnosis
• Coughing, fast breathing, or reduced exercise tolerance

Seek emergency care if your dog shows:

• A fever (rectal temperature above 103.5°F) within 7 to 10 days of a chemotherapy dose
• Severe vomiting or diarrhea, especially with blood
• Collapse, severe weakness, or pale-to-white gums
• Difficulty breathing or open-mouth breathing at rest
• Sudden swelling of the face, neck, or front legs
• Seizures or sudden disorientation

Talking about end of life

Most dogs with lymphoma eventually relapse — sometimes after a few months, sometimes after a year or more. Second-line protocols (rescue chemotherapy with different drugs) can produce additional remissions, but those remissions are usually shorter than the first. There comes a point, for most families, where the right next step is no longer another round of treatment but a focus on comfort and on letting the dog go peacefully when his quality of life can no longer be maintained.

Quality of life scales — the HHHHHMM scale, the JOURNEYS scale, simple good-day/bad-day calendars — give you a structured, compassionate way to track how your dog is really doing. Honest conversations with your veterinarian or oncologist can help you recognize when more days of treatment are no longer adding more good days of life. There is no "right" moment, only the moment that feels least wrong, made with love and with eyes wide open.

Compassion and hope

A diagnosis of lymphoma is one of the harder phone calls an owner ever takes. The disease is serious, the language is unfamiliar, and the calendar of treatments and rechecks suddenly fills the next several months of your life. It is reasonable to feel afraid. It is also reasonable to feel hopeful.

For most dogs treated with modern protocols, lymphoma becomes a manageable presence rather than an immediate ending. Lymph nodes shrink within days. Energy returns within a week. Walks resume, dinners are eaten, the tail wags at the door. The treatments are not painless and not free, but they buy real, meaningful time — months and often a year or more of the dog you have always known. And during those months, the work of love is unchanged: you make breakfast, you go for walks, you scratch behind the ears, you sit together on the couch, and you remind a very good dog, one ordinary day at a time, that he is not facing this alone.

This article provides general educational information about lymphoma in dogs. It is not a substitute for individualized veterinary advice. Every dog and every cancer is different, and decisions about diagnosis, staging, and treatment should always be made in partnership with a veterinarian — and ideally, for ongoing oncology care, a board-certified veterinary oncologist — who can examine your dog and interpret his specific bloodwork, imaging, and biopsy results. Never start prednisone, supplements, or any new medication for a suspected mass without veterinary guidance, and never delay evaluation of a new lymph node swelling in a senior dog. If your dog develops a fever during chemotherapy, severe weakness, pale gums, sudden facial or limb swelling, or breathing difficulty, seek emergency veterinary care immediately rather than waiting for a scheduled appointment.